Outcome

This study examined how hyperbaric oxygen therapy (HBOT) affects anxiety and social behaviors in mice with Fragile X Syndrome (FXS). Results indicated HBOT reduced anxiety in several behavioral tests and increased social interactions suggesting HBOT could be a potential treatment for FXS.

Introduction

Fragile X Syndrome (FXS) is a common mental retardation syndrome characterized by anxiety and altered social behaviors. This study explores the potential of hyperbaric oxygen therapy (HBOT) to address these symptoms. Using Fmr1 knockout mice a model for FXS the researchers examined the impact of HBOT on anxiety-related and social behaviors. The results showed that HBOT-treated mice exhibited more thigmotaxis an indication of increased anxiety in the open field test. However in the elevated plus maze test these mice demonstrated enhanced motor activity and fewer anxiety-related behaviors compared to control mice. Furthermore in the three-chambered social approach test HBOT-treated mice displayed higher levels of social interaction and reduced “social anxiety.” These findings suggest that HBOT could potentially alter anxiety and social behaviors in FXS offering a promising therapeutic strategy.

Results

The study aimed to evaluate the effects of Hyperbaric Oxygen Therapy (HBOT) on anxiety and social behaviors in Fmr1 knockout mice which serve as a model for Fragile X Syndrome (FXS) a condition marked by anxiety and social behavior anomalies.

In the open field test HBOT group mice exhibited increased thigmotaxis spending more time near the walls of the arena which suggests higher anxiety levels compared to the control group. However in the elevated plus maze test the HBOT group mice displayed a significant increase in the percentage of distance traveled on the open arms indicating reduced anxiety-related behaviors and enhanced motor activity compared to the control group.

The social behaviors were evaluated using the three-chambered social approach test. Results revealed that HBOT group mice showed an increase in social interaction and decreased “social anxiety.” In the sociability test HBOT group mice made more approaches to an acquaintance mouse and in the social novelty preference test they made more approaches to a stranger mouse than the control group.

These findings indicate that HBOT can alter anxiety and social behaviors in a FXS mouse model suggesting it may be a potential treatment for Fragile X Syndrome.

Conclusion

In conclusion this study delved into the effects of hyperbaric oxygen therapy (HBOT) on anxiety-related and social behaviors in Fmr1 knockout mice which serve as a model for Fragile X Syndrome (FXS). The results were quite promising showing that HBOT group mice exhibited different behaviors indicative of altered anxiety and improved social interaction. For instance while the increased thigmotaxis (wall hugging) in the open field test indicated heightened anxiety the enhanced motor activity in the open arm of the elevated plus maze test suggested reduced anxiety-related behaviors. Additionally HBOT group mice displayed a marked increase in social interaction and decreased “social anxiety” in the three-chambered social approach test. These findings suggest that HBOT could potentially be a new avenue for treating anxiety and social behavior issues in individuals with FXS. However the study did not specify the HBOT parameters and acknowledges no funding sources or conflicts of interest. While more research is needed these results offer a glimpse of hope for using HBOT as a treatment for Fragile X Syndrome.